HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Guzmán Selected Research

enflicoxib

3/2022Evaluation of the Genotoxic Potential of the Selective COX-2 Inhibitor Enflicoxib in a Battery of in vitro and in vivo Genotoxicity Assays.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Guzmán Research Topics

Disease

4Hypothermia
12/2008 - 12/2004
3Pain (Aches)
07/2022 - 06/2021
3Urinary Incontinence
07/2022 - 02/2021
2Chromosome Aberrations (Chromosome Abnormalities)
03/2022 - 02/2021
1Fibrosarcoma
07/2022
1Sarcoma (Soft Tissue Sarcoma)
07/2022
1Inflammation (Inflammations)
03/2022
1Osteoarthritis
03/2022
1Lymphoma (Lymphomas)
05/2008

Drug/Important Bio-Agent (IBA)

4E 5842IBA
12/2008 - 12/2004
3cizolirtineIBA
07/2022 - 02/2021
3sigma Receptors (sigma Receptor)IBA
12/2008 - 12/2004
3LigandsIBA
12/2008 - 12/2004
2Calcitonin Gene-Related PeptideIBA
07/2022 - 06/2021
2Substance PIBA
07/2022 - 06/2021
2Pharmaceutical PreparationsIBA
02/2021 - 05/2008
2Antipsychotic Agents (Antipsychotics)IBA
10/2008 - 05/2008
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2022
1enflicoxibIBA
03/2022
1Biological ProductsIBA
02/2021
1Chlorpromazine (Thorazine)FDA Link
10/2008

Therapy/Procedure

1Analgesia
02/2021
1Oral Administration
10/2008